Identification and validation of potential novel biomarkers for oral squamous cell carcinoma

References

• Sathiyasekar AC, Chandrasekar P, Pakash A, et al. Overview of immunology of oral squamous cell carcinoma. J Pharm Bioallied Sci. 2016;8:S8–s12.
   PubMed Web of Science ®Google Scholar
• Huang GZ, Wu QQ, Zheng ZN, et al. Identification of candidate biomarkers and analysis of prognostic values in oral squamous cell carcinoma. Front Oncol. 2019;9:1054.
   PubMed Web of Science ®Google Scholar
• Cao R, Wu Q, Li Q, et al. A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma. PeerJ. 2019;7:e7360.
   PubMed Web of Science ®Google Scholar
• Feng X, Luo Q, Wang H, et al. MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3. J Cell Physiol. 2018;233(9):6705–6713.
   PubMed Web of Science ®Google Scholar
• Zhao X, Sun S, Zeng X, et al. Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma. Am J Cancer Res. 2018;8:450–461.
   PubMed Web of Science ®Google Scholar
• Dickinson A, Saraswat M, Mäkitie A, et al. Label-free tissue proteomics can classify oral squamous cell carcinoma from healthy tissue in a stage-specific manner. Oral Oncol. 2018;86:206–215.
   PubMed Web of Science ®Google Scholar
• Sridharan G, Ramani P, Patankar S. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma. J Cancer Res Ther. 2017;13:556–561.
   PubMed Web of Science ®Google Scholar
• Xu C, Wang P, Liu Y, et al. Integrative genomics in combination with RNA interference identifies prognostic and functionally relevant gene targets for oral squamous cell carcinoma. PLoS Genet. 2013;9(1):e1003169.
   PubMed Web of Science ®Google Scholar
• Schiegnitz E, Kämmerer PW, Koch FP, et al. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma. Oral Oncol. 2012;48(7):608–614.
   PubMed Web of Science ®Google Scholar
• Ma J, Tang X, Sun WW, et al. Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma. Oncotarget. 2016;7(2):2113–2122.
   PubMedGoogle Scholar
• Tang X, Hu YJ, Ju WT, et al. Elevated growth differentiating factor 15 expression predicts long-term benefit of docetaxel, cisplatin and 5-fluorouracil induction chemotherapy in patients with oral cancer. Oncol Lett. 2018;15:8118–8124.
   PubMed Web of Science ®Google Scholar
• Schiegnitz E, Kämmerer PW, Schön H, et al. Proinflammatory cytokines as serum biomarker in oral carcinoma-A prospective multi-biomarker approach. J Oral Pathol Med. 2018;47(3):268–274.
   PubMed Web of Science ®Google Scholar
• Ni YH, Ding L, Hu QG, et al. Potential biomarkers for oral squamous cell carcinoma: proteomics discovery and clinical validation. Proteomics Clin Appl. 2015;9(1–2):86–97.
   PubMed Web of Science ®Google Scholar
• Chu HW, Chang KP, Hsu CW, et al. Identification of salivary biomarkers for oral cancer detection with untargeted and targeted quantitative proteomics approaches. Mol Cell Proteomics. 2019;18(9):1796–1806.
   PubMed Web of Science ®Google Scholar
• Tung CL, Lin ST, Chou HC, et al. Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma. J Pharm Biomed Anal. 2013;75:7–17.
   PubMed Web of Science ®Google Scholar
• Boccellino M, Pinto F, Ieluzzi V, et al. Proteomics analysis of human serum of patients with non-small-cell lung cancer reveals proteins as diagnostic biomarker candidates. J Cell Physiol. 2019;234(12):23798–23806.
   PubMed Web of Science ®Google Scholar
• Kohli M, Oberg AL, Mahoney DW, et al. Serum proteomics on the basis of discovery of predictive biomarkers of response to androgen deprivation therapy in advanced prostate cancer. Clin Genitourin Cancer. 2019;17(4):e7.
   PubMed Web of Science ®Google Scholar
• Ahn SB, Sharma S, Mohamedali A, et al. Potential early clinical stage colorectal cancer diagnosis using a proteomics blood test panel. Clin Proteomics. 2019;16(1):34.
   PubMed Web of Science ®Google Scholar
• Guo Y, Sheng Q, Li J, et al.Samuels DC, Shyr Y. Large scale comparison of gene expression levels by microarrays and RNAseq using TCGA data. PLoS One. 2013;8(8):e71462.
   PubMed Web of Science ®Google Scholar
• (2010) pROC-package.
   Google Scholar
• Patil I (2018) ‘ggplot2ʹ based plots with statistical details [R package ggstatsplot version 0.0.1].
   Google Scholar
• Han HY, Kim HJ, Jeong SH, et al. The flavonoid jaceosidin from artemisia princeps induces apoptotic cell death and inhibits the akt pathway in oral cancer cells. Evid Based Complement Alternat Med. 2018;2018:5765047.
   Google Scholar
• Necula L, Matei L, Dragu D, et al. Recent advances in gastric cancer early diagnosis. World J Gastroenterol. 2019;25(17):2029–2044.
   PubMed Web of Science ®Google Scholar
• Santosh AB, Jones T, Harvey J. A review on oral cancer biomarkers: understanding the past and learning from the present. J Cancer Res Ther. 2016;12(2):486–492.
   PubMed Web of Science ®Google Scholar
• Yang CZ, Ma J, Zhu DW, et al. GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma. Ann Oncol. 2014;25(6):1215–1222.
   PubMed Web of Science ®Google Scholar
• Andisheh-Tadbir A, Khademi B, Kamali F, et al. Upregulation of serum vascular endothelial growth factor and matrix metalloproteinase-3 in patients with oral squamous cell carcinoma. Tumor Biol. 2014;35(6):5689–5693.
   PubMedGoogle Scholar
• Jin Y, Li Y, Wang X, et al. Dysregulation of MiR-519d affects oral squamous cell carcinoma invasion and metastasis by targeting MMP3. J Cancer. 2019;10(12):2720–2734.
   PubMed Web of Science ®Google Scholar
• Mirzaii-Dizgah I, Mirzaii-Dizgah I, Mahboobi N, et al. Serum and Saliva MMP-3 in patients with OLP and oral SCC. J Contemp Dent Pract. 2015;16(2):107–111.
   PubMedGoogle Scholar
• Li HX, Zheng JH, Fan HX, et al. Expression of αvβ6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications. J Oral Pathol Med. 2013;42(7):547–556.
   PubMed Web of Science ®Google Scholar
• Gay CM, Balaji K, Byers LA. Giving AXL the axe: targeting AXL in human malignancy. Br J Cancer. 2017;116(4):415–423.
   PubMed Web of Science ®Google Scholar
• Chiu KC, Lee CH, Liu SY, et al. Polarization of tumor-associated macrophages and Gas6/Axl signaling in oral squamous cell carcinoma. Oral Oncol. 2015;51(7):683–689.
   PubMed Web of Science ®Google Scholar
• Paccez JD, Duncan K, Vava A, et al. Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma. Mol Biol Cell. 2015;26(5):821–831.
   PubMed Web of Science ®Google Scholar
• Lee CH, Yen CY, Liu SY, et al. Axl is a prognostic marker in oral squamous cell carcinoma. Ann Surg Oncol. 2012;19(Suppl S3):S500–8.
   PubMed Web of Science ®Google Scholar
• Abboud-Jarrous G, Priya S, Maimon A, et al. Protein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL. Oncotarget. 2017;8(8):13986–14002.
   PubMedGoogle Scholar
• Li YY, Tao YW, Gao S, et al. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EBioMedicine. 2018;36:209–220.
   PubMed Web of Science ®Google Scholar
• Rojo R, Pridans C, Langlais D, et al. Transcriptional mechanisms that control expression of the macrophage colony-stimulating factor receptor locus. Clin Sci. 2017;131(16):2161–2182.
   Web of Science ®Google Scholar
• Bonelli S, Geeraerts X, Bolli E, et al. Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages. FEBS J. 2018;285(4):777–787.
   PubMed Web of Science ®Google Scholar
• Chen XJ, Han LF, Wu XG, et al. Clinical Significance of CD163+ and CD68+ tumor-associated macrophages in high-risk HPV-related cervical cancer. J Cancer. 2017;8(18):3868–3875.
   PubMed Web of Science ®Google Scholar
• Qiu C, Xie Q, Zhang D, et al. GM-CSF induces cyclin D1 expression and proliferation of endothelial progenitor cells via PI3K and MAPK signaling. Cell Physiol Biochem. 2014;33(3):784–795.
   PubMedGoogle Scholar
• Hercus TR, Broughton SE, Ekert PG, et al. The GM-CSF receptor family: mechanism of activation and implications for disease. Growth Factors. 2012;30(2):63–75.
   PubMed Web of Science ®Google Scholar
• Wagai S, Kasamatsu A, Iyoda M, et al. UNC93B1 promotes tumoral growth by controlling the secretion level of granulocyte macrophage colony-stimulating factor in human oral cancer. Biochem Biophys Res Commun. 2019;513(1):81–87.
   PubMed Web of Science ®Google Scholar
• Haque NS, Zhang X, French DL, et al. CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation. 2000;102(7):786–792.
   PubMed Web of Science ®Google Scholar
• Haque NS, Fallon JT, Taubman MB, et al. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium. Blood. 2001;97(1):39–45.
   PubMed Web of Science ®Google Scholar
• Mildner M, Prior M, Gschwandtner M, et al. Epidermal CCL27 expression is regulated during skin development and keratinocyte differentiation. J Invest Dermatol. 2014;134(3):855–858.
   PubMed Web of Science ®Google Scholar
• Cai D, Xu Y, Ding R, et al. Extensive serum biomarker analysis in patients with non-small-cell lung carcinoma. Cytokine. 2020;126:154868.
   PubMed Web of Science ®Google Scholar
• Karnezis T, Farnsworth RH, Harris NC, et al. CCL27/CCL28-CCR10 chemokine signaling mediates migration of lymphatic endothelial cells. Cancer Res. 2019;79(7):1558–1572.
   PubMed Web of Science ®Google Scholar